| User's Publication |
|
19816
J V, Palo A, Besra K, Dixit M.
Gallbladder cancer-associated genetic variants rs1003349 and rs1004030 regulate MMP14 expression by altering SOX10- and MYB-binding sites
Hum Mol Genet
2023
32(14):2357-2372
PubMed ID: 37162337
DOI: 10.1093/hmg/ddad077
|
|
20980
Takahashi M, Tsuchikawa T, Hiwasa T, Nakamura T, Hontani K, Kushibiki T, Inoko K, Takano H, Hatanaka Y, Matsushita K, Matsubara H, Hoshino T, Ohtsuka M, Shimada H, Tanaka K, Nakanishi Y, Asano T, Noji T, Okamura K, Shichinohe T, Hirano S.
Identification of antibody against wingless‑type MMTV integration site family member 7B as a biliary cancer tumor marker.
Oncol Rep
2023
49(2)
PubMed ID: 36562381
DOI: 10.3892/or.2022.8471
|
|
20567
Jain AP, Sambath J, Sathe G, George IA, Pandey A, Thompson EW, Kumar P.
Pan-cancer quantitation of epithelial-mesenchymal transition dynamics using parallel reaction monitoring-based targeted proteomics approach.
J Transl Med
2022
20(1):84
PubMed ID: 35148768
DOI: 10.1186/s12967-021-03227-0
|
|
13261
Brägelmann J, Barahona Ponce C, Marcelain K, Roessler S, Goeppert B, Gallegos I, Colombo A, Sanhueza V, Morales E, Rivera MT, de Toro G, Ortega A, Müller B, Gabler F, Scherer D, Waldenberger M, Reischl E, Boekstegers F, Garate-Calderon V, Umu SU, Rounge TB, Popanda O, Lorenzo Bermejo J.
Epigenome-wide analysis of methylation changes in the sequence of gallstone disease, dysplasia, and gallbladder cancer.
Hepatology
2021
73(6):2293-2310.
PubMed ID: 33020926
DOI: 10.1002/hep.31585
|
|
13509
Ebata N, Fujita M, Sasagawa S, Maejima K, Okawa Y, Hatanaka Y, Mitsuhashi T, Oosawa-Tatsuguchi A, Tanaka H, Miyano S, Nakamura T, Hirano S, Nakagawa H.
Molecular Classification and Tumor Microenvironment Characterization of Gallbladder Cancer by Comprehensive Genomic and Transcriptomic Analysis
Cancers (Basel)
2021
13(4):733
PubMed ID: 33578820
DOI: 10.3390/cancers13040733
|
|
20194
Ueta E, Tsutsumi K, Kato H, Matsushita H, Shiraha H, Fujii M, Matsumoto K, Horiguchi S, Okada H.
Extracellular vesicle-shuttled miRNAs as a diagnostic and prognostic biomarker and their potential roles in gallbladder cancer patients.
Sci Rep
2021
11(1):12298
PubMed ID: 34112884
DOI: 10.1038/s41598-021-91804-0
|
|
20381
Qin Y, Zheng Y, Huang C, Li Y, Gu M, Wu Q.
Knockdown of circSMAD2 inhibits the tumorigenesis of gallbladder cancer through binding with eIF4A3.
BMC Cancer
2021
21(1):1172
PubMed ID: 34727877
DOI: 10.1186/s12885-021-08895-1
|
|
16131
Tóth M, Wehling L, Thiess L, Rose F, Schmitt J, Weiler SME, Sticht C, De La Torre C, Rausch M, Albrecht T, Grabe N, Duwe L, Andersen JB, Köhler BC, Springfeld C, Mehrabi A, Kulu Y, Schirmacher P, Roessler S, Goeppert B, Breuhahn K.
Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma
BMC Cancer
2021
21(1):1079
PubMed ID: 34615513
DOI: 10.1186/s12885-021-08794-5
|
|
17034
Qin Y, Zheng Y, Huang C, Li Y, Gu M, Wu Q.
Downregulation of miR-181b-5p Inhibits the Viability, Migration, and Glycolysis of Gallbladder Cancer by Upregulating PDHX Under Hypoxia
Front Oncol
2021
11:683725
PubMed ID: 34485121
DOI: 10.3389/fonc.2021.683725
|
|
11936
Yu J, Shi L, Lin W, Lu B, Zhao Y.
UCP2 promotes proliferation and chemoresistance through regulating the NF-κB/β-catenin axis and mitochondrial ROS in gallbladder cancer.
Biochem. Pharmacol.
2020
PubMed ID: 31811866
DOI: 10.1016/j.bcp.2019.113745
|
|
12106
García P, Rosa L, Vargas S, Weber H, Espinoza JA, Suárez F, Romero-Calvo I, Elgueta N, Rivera V, Nervi B, Obreque J, Leal P, Viñuela E, Aguayo G, Muñiz S, Sagredo A, Roa JC, Bizama C.
Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer.
Cancers (Basel)
2020
PubMed ID: 32218280
DOI: 10.3390/cancers12040778
|
|
12131
García P, Bizama C, Rosa L, Espinoza JA, Weber H, Cerda-Infante J, Sánchez M, Montecinos VP, Lorenzo-Bermejo J, Boekstegers F, Dávila-López M, Alfaro F, Leiva-Acevedo C, Parra Z, Romero D, Kato S, Leal P, Lagos M, Roa JC.
Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor.
Biol. Res.
2020
PubMed ID: 32293552
DOI: 10.1186/s40659-020-00282-7
|
|
13185
Pandey A, Stawiski EW, Durinck S, Gowda H, Goldstein LD, Barbhuiya MA, Schröder MS, Sreenivasamurthy SK, Kim SW, Phalke S, Suryamohan K, Lee K, Chakraborty P, Kode V, Shi X, Chatterjee A, Datta K, Khan AA, Subbannayya T, Wang J, Chaudhuri S, Gupta S, Shrivastav BR, Jaiswal BS, Poojary SS, Bhunia S, Garcia P, Bizama C, Rosa L, Kwon W, Kim H, Han Y, Yadav TD, Ramprasad VL, Chaudhuri A, Modrusan Z, Roa JC, Tiwari PK, Jang JY, Seshagiri S.
Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate.
Nat Commun
2020
PubMed ID: 32839463
DOI: 10.1038/s41467-020-17880-4
|
|
13843
Cristóbal Calderón-Reyes, Ramón Silva Pezoa, Pamela Leal, Alejandra Ribera-Fonseca, Cristina Cáceres, Ismael Riquelme, Tomas Zambrano, Daniela Peña, Miren Alberdi & Marjorie Reyes-Díaz
Anthocyanin-Rich Extracts of Calafate (Berberis microphylla G. Forst.) Fruits Decrease In Vitro Viability and Migration of Human Gastric and Gallbladder Cancer Cell Lines
Journal of Soil Science and Plant Nutrition
2020
20:1891–1903
DOI: 10.1007/s42729-020-00260-8
|
|
13924
Qin Y, Mi W, Huang C, Li J, Zhang Y, Fu Y.
Downregulation of miR-575 Inhibits the Tumorigenesis of Gallbladder Cancer via Targeting p27 Kip1
Onco Targets Ther
2020
13:3667-3676
PubMed ID: 32431517
DOI: 10.2147/OTT.S229614
|
|
20122
Hendaoui I, Lahmar A, Campo L, Mebarki S, Bichet S, Hess D, Degen M, Kchir N, Charrada-Ben Farhat L, Hefaiedh R, Ruiz C, Terracciano LM, Tucker RP, Hendaoui L, Chiquet-Ehrismann R.
Tenascin-W Is a Novel Stromal Marker in Biliary Tract Cancers.
Front Immunol
2020
11:630139
PubMed ID: 33692777
DOI: 10.3389/fimmu.2020.630139
|
|
11395
Subbannayya T, Leal-Rojas P, Zhavoronkov A, Ozerov IV, Korzinkin M, Babu N, Radhakrishnan A, Chavan S, Raja R, Pinto SM, Patil AH, Barbhuiya MA, Kumar P, Guerrero-Preston R, Navani S, Tiwari PK, Kumar RV, Prasad TSK, Roa JC, Pandey A, Sidransky D, Gowda H, Izumchenko E, Chatterjee A.
PIM1 kinase promotes gallbladder cancer cell proliferation via inhibition of proline-rich Akt substrate of 40 kDa (PRAS40).
J Cell Commun Signal
2019
PubMed ID: 30666556
DOI: 10.1007/s12079-018-00503-5
|
|
3726
Kirti Gondkar, Krishna Patel, Geeta V. Patil Okaly, Bipin Nair, Akhilesh Pandey, Harsha Gowda and Prashant Kumar
Dickkopf Homolog 3 (DKK3) Acts as a Potential Tumor Suppressor in Gallbladder Cancer
Front Oncol
2019
9:1121
PubMed ID: 31737564
DOI: 10.3389/fonc.2019.01121
|
|
11742
Qin Y, Zhou Y, Ge A, Chang L, Shi H, Fu Y, Luo Q.
Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo.
Biomed. Pharmacother.
2019
PubMed ID: 31401397
DOI: 10.1016/j.biopha.2019.109266
|
|
10170
Weber H, Valbuena JR, Barbhuiya MA, Stein S, Kunkel H, García P, Bizama C, Riquelme I, Espinoza JA, Kurtz SE, Tyner JW, Calderon JF, Corvalán AH, Grez M, Pandey A, Leal-Rojas P, Roa JC.
Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer.
Oncotarget
2017
8:26169-26184
PubMed ID: 28412732
DOI: 10.18632/oncotarget.15410
|
|
10222
Yang L, Huang S, Ma H, Wu X, Feng F.
MicroRNA-125b predicts clinical outcome and suppressed tumor proliferation and migration in human gallbladder cancer.
Tumour Biol.
2017
39:1010428317692249
PubMed ID: 28347246
DOI: 10.1177/1010428317692249
|
|
3727
Yeung Y, Lau DK, Chionh F, Tran H, Tse JWT, Weickhardt AJ, Nikfarjam M, Scott AM, Tebbutt NC, Mariadason JM
K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines.
Mol Oncol
2017
11(9):1130-1142
PubMed ID: 28544747
DOI: 10.1002/1878-0261.12078
|
|
9533
Tadokoro T, Morishita A, Fujihara S, Iwama H, Niki T, Fujita K, Akashi E, Mimura S, Oura K, Sakamoto T, Nomura T, Tani J, Miyoshi H, Yoneyama H, Himoto T, Hirashima M, Masaki T.
Galectin-9: An anticancer molecule for gallbladder carcinoma.
Int. J. Oncol.
2016
48:1165-74
PubMed ID: 26797414
DOI: 10.3892/ijo.2016.3347
|
|
3735
Saha SK et al
Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma.
Cancer Discov
2016
6(7):727-39
PubMed ID: 27231123
DOI: 10.1158/2159-8290.CD-15-1442
|
|
7355
Saeki N, Ono H, Sakamoto H, Yoshida T.
Down-regulation of Immune-related Genes by PSCA in Gallbladder Cancer Cells Implanted into Mice.
Anticancer Res.
2015
35:2619-25
PubMed ID: 25964537
|
|
3691
Weber H, Leal P, Stein S, Kunkel H, García P, Bizama C, Espinoza JA, Riquelme I, Nervi B, Araya JC, Grez M, Roa JC.
Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice.
Oncotarget
2015
6(31):31877-88
PubMed ID: 26397134
DOI: 10.18632/oncotarget.5047
|
|
3729
Subbannayya T et al
Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer.
BMC Cancer
2015
15:843
PubMed ID: 26530123
DOI: 10.1186/s12885-015-1855-z
|
|
18710
Kono H, Nakamura M, Ohtsuka T, Nagayoshi Y, Mori Y, Takahata S, Aishima S, Tanaka M.
High expression of microRNA-155 is associated with the aggressive malignant behavior of gallbladder carcinoma
Oncol Rep
2013
30(1):17-24
PubMed ID: 23660842
DOI: 10.3892/or.2013.2443
|
Back
Top
CELL BANK Website
